| | | | | | | | | | |
|
| |
|
| Dockets Entered
On April 23, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
|
|
| 1981N-0050
|
| OTC for treatment of acute toxic ingestion human use
|
|
|
|
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
|
|
| 1996V-0210
|
| Variance for Laser Light Show
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| 1999V-0190
|
| Variance Laser Light Show LSD110XL MRAK10 & MRAK250
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| 2000P-1322
|
| Food Labeling and Allergen Contamination Control
|
|
|
|
|
| 2000P-1439
|
| Iceberg Water Deviating From Identity Standard
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2002P-0520
|
| Reclassification of Beta-Tricalcium Phosphate,
|
|
|
|
|
| 2003D-0570
|
| Draft on the Clinical Evaluation of Weight-Control Drugs
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003N-0324
|
| New Animal Drugs; Removal of Obsolete and Redundant Regulations
|
|
|
|
|
| 2003N-0327
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Request For a Meeting or Teleconference to the Office of New Anim
|
|
|
|
|
|
|
|
|
| 2003N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point (HAACP); Procedures for the Safe and Sanitary Processing and Importing of Jui
|
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| 2003P-0479
|
| Allow importation of Canadian versions of drugs that are approved to the United States
|
|
|
|
|
| 2004D-0156
|
| International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Guidance for Industry on b
|
|
|
|
|
| 2004N-0086
|
| Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
|
|
|
|
|
| 2004N-0166
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Infant Feeding Practices Study II
|
|
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
|
|
| 2004V-0119
|
| Laser Light Show
|
|
|
|
|
| 2004V-0138
|
| Laser Light Show
|
|
|
|
|
| 2004V-0190
|
| LaserLlight Show
|
|
|
|
|
| 2004V-0191
|
| Laser Light Show
|
|
| |
|
| 1981N-0050
|
| OTC for treatment of acute toxic ingestion human use
|
|
|
|
|
| SUP
1
Appendix 1, 2,
3
|
| American Assn of Poison Control Centers (AAPCC)
|
| Vol #:
|
| 1
|
|
| |
|
| 1992N-0297
|
| Prescription Drug Marketing Act of 1987, Drug Amds of 1992
|
|
|
|
|
| C
130
Tab 1
|
| Pharmaceutical Distributors
Assn (PDA)
|
| Vol #:
|
| 10
|
|
|
|
|
| 1996V-0210
|
| Variance for Laser Light Show
|
|
|
|
|
| VRA
5
|
| HFZ-300 to LaserSmith Light Show Systems
|
| Vol #:
|
| 1
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
| | | | | | | | |
|
|
|
|
| LET
13776
|
| The Fitzpatrick Group, Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13777
|
| BioAdvantex Pharm Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13778
|
| BioAdvantex Pharm Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13779
|
| Herb Pharm
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13780
|
| Michael's Naturopathic Programs
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13781
|
| Nature's Sunshine Products, Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13782
|
| AdvoCare
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13783
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13784
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13785
|
| Integrative Therapeutics Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13786
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13787
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13788
|
| Perrigo Company of South Carlina
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13789
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 116
|
|
|
|
|
| LET
13790
|
| Market America, Inc.
|
| Vol #:
|
| 116
|
|
|
|
|
| 1998D-1146
|
| Microbial effects of antimicrobial new animal drugs/human sa
|
|
|
|
|
| C
106
Continued
|
| Animal Health Institute (AHI)
|
| Vol #:
|
| 62
|
|
|
|
|
| 1999V-0190
|
| Variance Laser Light Show LSD110XL MRAK10 & MRAK250
|
|
|
|
|
| VRA
3
|
| HFZ-300 to Artistic Laser Productions
|
| Vol #:
|
| 1
|
|
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
|
|
| EMC 5819
|
| Gillie Ocepack
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5820
|
| Elizabeth Kempf
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5821
|
| Elizabeth Kempf
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5822
|
| Jeff Cordulack
|
| Vol #:
|
| 789
|
|
|
|
|
| EMC 5823
|
| Chris Thiel
|
| Vol #:
|
| 789
|
|
|
|
|
| 2000P-1322
|
| Food Labeling and Allergen Contamination Control
|
|
|
|
|
| C 545
|
| C. Jahrling
|
| Vol #:
|
| 30
|
|
|
|
|
| 2000P-1439
|
| Iceberg Water Deviating From Identity Standard
|
|
|
|
|
| LET
2
|
| HFS-822 to Iceberg Industries Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| C 1342
|
| Form Letter
|
| Vol #:
|
| 212
|
|
|
|
|
| C 1343
|
| Form Letter
|
| Vol #:
|
| 215
|
|
|
|
|
| C 1344
|
| Form Letter
|
| Vol #:
|
| 228
|
|
| | | | | | | | |
|
|
|
|
| C
3
|
| Eli Lilly and Company (Lilly)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| C
22
|
| Daniels Midland Company (ADM)
|
| Vol #:
|
| 7
|
|
|
|
|
| C
23
|
| Stephan Company
|
| Vol #:
|
| 7
|
|
|
|
|
| 2003N-0324
|
| New Animal Drugs; Removal of Obsolete and Redundant Regulations
|
|
|
|
|
| BKG
2
|
| Background Material Refs 1 - 14
|
| Vol #:
|
| 3
|
|
|
|
|
| NPR
2
|
| FDA
|
| Vol #:
|
| 3
|
|
|
|
|
| 2003N-0327
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Request For a Meeting or Teleconference to the Office of New Anim
|
|
|
|
|
|
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point (HAACP); Procedures for the Safe and Sanitary Processing and Importing of Jui
|
|
|
|
|
|
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
|
|
| C
9
|
| Honeywell Chemicals
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003P-0479
|
| Allow importation of Canadian versions of drugs that are approved to the United States
|
|
|
|
|
| LET
1
|
| HFD-005 to The City of Springfield, Massachusetts
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004D-0156
|
| International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products (VICH); Guidance for Industry on b
|
|
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0086
|
| Diabetes: Targeting Safe and Effective Prevention and Treatment; Public Meeting
|
|
|
|
|
| C
2
|
| G. Lewis RN,BC,EdM,CDE
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0166
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Infant Feeding Practices Study II
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004V-0119
|
| Laser Light Show
|
|
|
|
|
| VRA
1
|
| HFZ-300 to John Coodey CLLS
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004V-0138
|
| Laser Light Show
|
|
